###begin article-title 0
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma
###end article-title 0
###begin p 1
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 562 574 562 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1, NTHL1</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUDT1</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 487 495 <span type="species:ncbi:9606">patients</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
###xml 1394 1402 <span type="species:ncbi:9606">patients</span>
The human hMYH and NEIL1 genes encode DNA glycosylases involved in repair of oxidative base damage and mutations in these genes are associated with certain cancers. Primary sclerosing cholangitis (PSC), a chronic cholestatic liver disease characterized by inflammatory destruction of the biliary tree, is often complicated by the development of cholangiocarcinoma (CCA). Here, we aimed to investigate the influence of genetic variations in the hMYH and NEIL1 genes on risk of CCA in PSC patients. The hMYH and NEIL1 gene loci in addition to the DNA repair genes hOGG1, NTHL1 and NUDT1 were analyzed in 66 PSC patients (37 with CCA and 29 without cancer) by complete genomic sequencing of exons and adjacent intronic regions. Several single-nucleotide polymorphisms and mutations were identified and severe impairment of protein function was observed for three non-synonymous variants. The NEIL1 G83D mutant was dysfunctional for the major oxidation products 7,8-dihydro-8-oxoguanine (8oxoG), thymine glycol and dihydrothymine in duplex DNA, and the ability to perform delta-elimination at abasic sites was significantly reduced. The hMYH R260Q mutant had severe defect in adenine DNA glycosylase activity, whereas hMYH H434D could excise adenines from A:8oxoG pairs but not from A:G mispairs. We found no overall associations between the 18 identified variants and susceptibility to CCA in PSC patients; however, the impaired variants may be of significance for carcinogenesis in general. Our findings demonstrate the importance of complete resequencing of selected candidate genes in order to identify rare genetic variants and their possible contribution to individual susceptibility to cancer development.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">3</xref>
###xml 605 606 605 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
Oxidative DNA damage induced by reactive oxygen species is a major source of mutation load in living organisms and is believed to play a causative role in aging and degenerative diseases such as cancer (1,2). Reactive oxygen species are formed as by-products of the electron transport machinery, during conditions of chronic inflammation and by exogenous stimuli such as ionizing radiation and various chemical oxidants (3). 7,8-dihydro-8-oxoguanine (8oxoG) is one of the most stable products of oxidative DNA damage and has deleterious effects because it can mispair with adenine during DNA replication (4,5). Many tumors have been shown to have G:C to T:A transversion mutations associated with 8oxoG and also to have increased levels of 8oxoG in the DNA (6-8).
###end p 3
###begin p 4
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1099 1101 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
To counteract the potential harmful effects of oxidative DNA damage, cells primarily use the base excision repair (BER) pathway. BER is initiated by lesion-specific DNA glycosylases that identify and excise the damaged base, leaving an abasic (apurinic/apyrimidinic) site in the DNA that is further processed by the other enzymes of the BER pathway (reviewed in ref. 9). Mammalian cells are equipped with several different DNA glycosylases and 8oxoG DNA glycosylase (hOGG1) is the major enzyme for removal of 8oxoG from an 8oxoG:C pair but not when 8oxoG is already mispaired with adenine. In this case, A is removed by adenine DNA glycosylase (hMutY/hMYH) (reviewed in ref. 10). Finally, the NUDT1 (MutT in bacteria) enzyme hydrolyzes 8oxoG triphosphate to 8oxoG monophosphate, thus avoiding the incorporation of oxidized nucleotides into genomic DNA. The DNA glycosylases endonuclease III (NTHL1) and endonuclease VIII-like 1 (NEIL1) are the principal enzymes for removal of oxidized pyrimidines such as thymine glycol (Tg), 5-hydroxy cytosine (5ohC) and 5-hydroxy uracil (5ohU) (reviewed in ref. 11).
###end p 4
###begin p 5
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
Recent studies suggest that polymorphisms in DNA glycosylase genes are associated with several cancers. For example, polymorphisms in NEIL1 have been linked to gastric cancer (12), whereas those in hOGG1 have been related to higher risk for prostate (13) and lung cancer (reviewed in ref. 14). For the hMYH gene, inactivating mutations and polymorphisms are associated with development of colorectal polyposis (MutY associated-polyposis) (7,15). Also, approaches based on functional analyses have shown that reduced 8oxoG DNA glycosylase activity is a risk factor in lung, head and neck cancer (16,17).
###end p 5
###begin p 6
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 1405 1413 <span type="species:ncbi:9606">patients</span>
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the bile ducts leading to bile duct strictures and eventually liver cirrhosis and liver transplantation (18). Importantly, PSC is a considerable risk factor for the development of cholangiocarcinoma (CCA) that results from a malignant transformation of bile duct epithelial cells. The prevalence of CCA in PSC ranges from 6-13% in most reports (19-21). The duration and severity of PSC does not seem to correlate with development of CCA, suggesting that individual susceptibility factors are important (22,23). As recently demonstrated (24), genetic variants may influence risk of CCA in PSC. Further, an emerging concept in association studies is that rare sequence variants with strong phenotypic effects might contribute substantially to the aggregated risk of complex traits, including cancer. The exact mechanism for CCA development in PSC is unknown. In experimental models, bile has been shown to induce oxidative stress and to increase oxidative DNA damage in cholangiocytes (25). Consequently, individual differences in processing of DNA damage could be of importance for transformation of the inflammatory changes of the biliary tree into cancer. In this study, we have evaluated the role of germ line variation in genes important for repair of oxidative DNA damage and their potential role for development of CCA in PSC patients.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 8
###begin p 9
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 889 890 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
###xml 562 569 <span type="species:ncbi:9606">patient</span>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 970 982 <span type="species:ncbi:9606">participants</span>
The study included 66 Scandinavian PSC patients recruited on admission to the Medical Department, Rikshospitalet University Hospital, Oslo, Norway, (n = 48) and Division of Gastroenterology and Hepatology, Karolinska University Hospital, Huddinge, Stockholm, Sweden (n = 18). PSC was diagnosed according to accepted criteria, including characteristic cholangiographic findings (18). Inflammatory bowel disease was diagnosed by colonoscopy with biopsies and classified according to standard criteria. The cohort comprised 37 (28 males) PSC patients with CCA (one patient with a carcinoma of the gallbladder was included in this group) and 29 (20 males) without cancer of the biliary tract. CCA was confirmed by histology. Concomitant inflammatory bowel disease had been diagnosed in 78% of the patients with CCA and in 86% of those without. An ethnically matched group of healthy controls (n = 30) was randomly selected from the Norwegian Bone Marrow Donor Registry. All participants gave their written informed consent. The study was approved by The Regional Committee for Research Ethics in Southern Norway and The Ethics Committee of Karolinska Institutet.
###end p 9
###begin title 10
DNA sequencing
###end title 10
###begin p 11
###xml 285 287 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Genomic DNA was extracted from peripheral blood leukocytes from PSC patients and controls and whole genome amplification was performed using the GenomiPhi(R) kit (GE Healthcare Systems, Chalfont St Giles, UK), yielding high molecular amplified DNA thoroughly validated for genotyping (26).
###end p 11
###begin p 12
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUDT1</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTHL1</italic>
###xml 149 163 149 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
The exons including flanking intronic regions of the genes hMYH, hOGG1, NEIL1, NUDT1 and NTHL1 were amplified using primers listed in  (available at Carcinogenesis Online). Detailed polymerase chain reaction conditions are freely available from the authors upon request. Subsequent sequencing (primers available upon request) was performed with BigDye(R) Terminator v3.1 chemistry (Applied Biosystems, Foster City, CA) and an ABI3730 capillary sequencer (Applied Biosystems) according to manufacturer's protocols. Subsequent mutation detection was performed using SeqScape v2.5 (Applied Biosystems).
###end p 12
###begin title 13
Construction and purification of hMYH, hOGG1 and NEIL1mutants
###end title 13
###begin p 14
###xml 72 86 72 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 265 270 265 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 691 707 691 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 752 766 752 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 911 925 911 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 691 707 <span type="species:ncbi:562">Escherichia coli</span>
Primers used for site-specific mutagenesis are listed in  (available at Carcinogenesis Online). pGEV1-hMYH (27) was used to generate the three hMYH mutants (R260Q, H434D and S501F) with QuickChange polymerase chain reaction. The hOGG1 gene was subcloned from pUC18-hOGG1 (28) into the EcoRI and BglII sites of pETDuet-1 (Novagen, Madison, WI) and this construct was used as the template to generate pETDuet-1-hOGG1-S31P. NEIL1cDNA subcloned into the NdeI and XhoI sites of pET22b was used as template to generate the two mutated constructs pET22b-NEIL1-G83D and pET22b-NEIL1-E181K. All constructs were verified by DNA sequencing of the entire open reading frames. Proteins were expressed in Escherichia coli and purified as described in  (available at Carcinogenesis Online). Purified proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel and detected by Coomassie Blue staining ( is available at Carcinogenesis Online).
###end p 14
###begin title 15
Assays for DNA glycosylase activity
###end title 15
###begin p 16
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5R</italic>
###xml 685 687 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Substrates for enzyme cleavage analysis were: 5'-ctcggtacccggggatctggccatg[A]ccgtgcaggcatgc (8oxoG or G opposite the marked A gave the A:8oxoG and A:G substrates, respectively); 5'-ggcggcatgaccc[8oxoG]gaggcccatc (C opposite 8oxoG gave the 8oxoG:C substrate); 5'-ctcgtcagcatca[Tg]catcatacagtcagtg (to yield the stereoisomer 5R Tg:A substrate) and 5'-gcatgcctgcacgg[x]catggccagatccccgggtaccgag [x is dihydrothymine (DHT), 5ohC, 5ohU or U with A, G, G or G, respectively, opposite the damage in the complementary strand gave the DHT:A, 5ohC:G, 5ohU:G or U:G substrates). All oligonucleotides were 5' end labeled with T4 polynucleotide kinase (New England Biolabs, Ipswich, MA) and [gamma-32P]adenosine triphosphate (Amersham Biosciences, Pittsburgh, PA). In order to generate double-stranded substrates, the labeled oligonucleotides were annealed to their respective complementary strands by heating the solution to 90degreesC for 2 min followed by slow cooling to room temperature. The U:G substrate was treated with uracil DNA glycosylase (New England Biolabs) to make the apurinic/apyrimidinic substrate.
###end p 16
###begin p 17
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Enzyme reactions were carried out in 70 mM 3-(N-morpholino)propanesulfonic acid, pH 7.5, 1 mM dithiothreitol, 1 mM ethylenediaminetetraacetic acid and 5% glycerol for 30 min at 37degreesC. Reaction mixtures contained 10 fmol substrate and enzymes as indicated in the figures in a total volume of 10 mul. To obtain strand cleavage after hMYH and hOGG1 base removal, NaOH (100 mM) was added to the reactions and incubation continued at 70degreesC for 15 min before neutralization with HCl (100 mM). All reactions were stopped by adding formamide DNA loading buffer. The reaction products were analyzed by 20% denaturing polyacrylamide gel electrophoresis and bands visualized by Phosphorimaging. Quantifications were done with the ImageQuant Software.
###end p 17
###begin p 18
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N&#8242;</italic>
###xml 218 220 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 318 319 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
FaPy DNA glycosylase assays were done in the same reaction buffer as above and [N-3H]methyl-N'-nitrosourea (18 Ci/mmol) was used to prepare poly (dG.dC) DNA containing faPy residues (5000 d.p.m./mug DNA) as described (29). Briefly, DNA glycosylase activity was measured in a total volume of 50 mul containing 0.4 mug [3H-]faPy-poly(dG-dC) with different amounts of enzyme as indicated. After incubation at 37degreesC for 30 min, DNA was precipitated with ethanol. The radioactivity of the supernatant was determined by scintillation counting.
###end p 18
###begin title 19
Electrophoretic mobility shift assays
###end title 19
###begin p 20
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
DNA binding of hMYH variants was determined by electrophoretic mobility shift assays (EMSAs) using 32P-5'-end labeled duplex DNA substrates containing an A:8oxoG or an A:G basepair. DNA (10 fmol) and enzymes as indicated in the figure were incubated on ice for 30 min in 20 mM Tris-HCl (pH7.5), 80 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 1 mM dithiothreitol and 3% glycerol in a total volume of 10 mul. Two-hundred femtomole competitor DNA (same duplex without damage) was included in all reactions. Reactions were stopped by adding 2 mul 6x DNA loading buffer (Fermentas, Ontario, Canada). Samples were analyzed on 10% native polyacrylamide gel electrophoresis in 1x Taurin at 4degreesC and visualized by Phosphorimaging. EMSAs for hOGG1 and NEIL1 enzymes were performed in the same buffer as the DNA glycosylase assays with substrates as indicated. hOGG1 samples were analyzed as for hMYH, whereas the NEIL1 samples were run in 0.5x Tris/Borate/EDTA.
###end p 20
###begin title 21
Intracellular localization of NEIL1 variants in HeLa cells
###end title 21
###begin p 22
###xml 203 204 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 425 430 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 432 434 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 443 448 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 461 466 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 99 103 <span type="species:ncbi:9913">calf</span>
HeLa S3cells were cultivated in Dulbecco's Modified Eagle's Medium with 4.5 g/l glucose, 10% fetal calf serum, 0.3 mg/ml glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin at 37degreesC in a 5% CO2 air atmosphere. Transfections of HeLa cells were done using FuGENE 6 Transfection Reagent (Roche Applied Science, Mannheim, Germany) according to the manufacturer's recommendations. Plasmids for transfections were pEGFP-NEIL1 (30), pEGFP-NEIL1-G83D, pEGFP-NEIL1-E181K and pEGFP-N1 (Clontech, Montain View, CA) as control. The site-specific mutants were generated by QuickChange polymerase chain reaction with the same primers as for the expression constructs.
###end p 22
###begin p 23
One or two days after transfection, the cells were stained with 5 mug/ml Hoechst 33342 (H-3570, Molecular Probes, Carlsbad, CA) at 37degreesC for 20 min and imaged directly with a Zeiss Axiovert 200M fluorescence microscope (Carl Zeiss, Jena, Germany).
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 134 145 134 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH, hOGG1</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUDT1</italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTHL1</italic>
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 9 17 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
DNA from patients with PSC (n = 29), PSC with CCA (n = 37) and healthy controls (n = 30) were screened for sequence variations in the hMYH, hOGG1, NEIL1, NUDT1 and NTHL1genes. In total, 18 sequence variants were identified in the coding regions of the five DNA repair genes examined (Table I). Association analysis with Bonferoni correction (18 tests) revealed no significant differences in genotype frequencies between PSC patients with and without CCA (Table I). Of the 18 variants, six were validated single-nucleotide polymorphisms (SNPs), whereas 12 were novel mutations.
###end p 25
###begin p 26
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tblfn1">a</xref>
Sequence changes and allele frequencies in four DNA repair genesa in healthy, PSC and PSC-CCA populations
###end p 26
###begin p 27
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTHL1</italic>
No genetic alterations were identified in the fifth gene sequenced; NTHL1.
###end p 27
###begin p 28
Part of this sequence is intronic.
###end p 28
###begin p 29
Amino acid changes subjected for functional studies.
###end p 29
###begin p 30
Name of an alternative transcript.
###end p 30
###begin p 31
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUDT1</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUDT1</italic>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTHL1</italic>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
In a functional perspective, two splice site mutations were found in two healthy controls in the NEIL1 and NUDT1 gene, respectively. Three of 12 novel mutations were synonymous, whereas nine were non-synonymous. All these 12 mutations were monoallelic and were found in the hMYH (4), hOGG1 (5) and NEIL1 (3) genes. For NUDT1, two frequent SNPs (V83M and D119) were found but no new mutations and, interestingly, no sequence variation at all was identified in the NTHL1 gene. All novel non-synonymous mutations (except one non-synonymous but conservative mutation) identified in the PSC or PSC-CCA patients were subjected to functional analysis.
###end p 31
###begin title 32
Analysis of hMYH
###end title 32
###begin p 33
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 161 170 161 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 271 298 271 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus stearothermophilus</italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 438 447 438 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 519 528 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 714 734 714 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.stearothermophilus</italic>
###xml 218 225 <span type="species:ncbi:9606">patient</span>
###xml 271 298 <span type="species:ncbi:1422">Bacillus stearothermophilus</span>
###xml 714 734 <span type="species:ncbi:1422">B.stearothermophilus</span>
Of the four non-synonymous hMYH mutations identified, one was in the healthy control group (E155Q) and three in the PSC group (R260Q, H434D and S501F) (Table I, Figure 1A). The S501F mutation was also found in one PSC patient with CCA. From the 3D structure of MutY from Bacillus stearothermophilus (31), it can be inferred that amino acid Arg260 in hMYH is located on the surface of hMYH, on the opposite side of the DNA-binding groove (Figure 1A). Further, His434 resides within a loop involved in 8oxoG recognition (Figure 1A) and interacts with the phosphate backbone of the DNA strand containing 8oxoG. Finally, Ser501 is in a region predicted to be disordered that is also outside of the structural model of B.stearothermophilus MutY.
###end p 33
###begin p 34
###xml 63 64 63 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 168 195 168 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bacillus stearothermophilus</italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 457 458 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 666 667 666 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 168 195 <span type="species:ncbi:1422">Bacillus stearothermophilus</span>
Schematic diagram and 3D structures of hMYH, hOGG1 and NEIL1. (A) Schematic diagram of the hMYH showing functional domains (left) and 3D structure (right) of MutY from Bacillus stearothermophilus in complex with DNA [Protein Data Bank identifier 1RRQ] (31). The positions of the mutations studied in this work, R260 and H434 are shown and were identified by amino acid sequence alignment of hMYH with BsMutY. Serine501 is outside of the ordered structure. (B) Schematic diagram showing functional domains (left) and 3D structure (right) of hOGG1 in complex with 8oxoG-containing DNA (Protein Data Bank identifier 1EBM) (32). The location of S31P mutation is shown. (C) Schematic diagram of NEIL1 showing functional domains (left) and 3D structure (right) (Protein Data Bank identifier 1TDH) (33) with position of G83 and E181 indicated. For hMYH domains interacting with RPA, MSH6, APE1 and PCNA are indicated. hOGG1 and NEIL1 have a conserved domain (blue) and the NEIL1 C-terminus is necessary for interactions with PCNA, DNA ligase III, DNA polymerase beta and XRCC1. The figures are not drawn to scale. Fe-S, Iron-sulfur cluster; H2TH, helix-2-turn-helix motif; HhH, helix-hairpin-helix motif; MTS, mitochondrial targeting signal; NLS, nuclear localization signal; Zn, zinc finger domain.
###end p 34
###begin p 35
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutY</italic>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 420 434 420 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 710 719 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 935 944 935 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1193 1202 1193 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1400 1409 1400 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1514 1523 1514 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1645 1654 1645 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 1859 1868 1859 1868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 2192 2201 2192 2201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 2522 2526 2522 2526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 151 157 <span type="species:ncbi:562">E.coli</span>
The three mutations found in the PSC patients were introduced into hMYH expression plasmids and the mutant proteins were expressed in a mutY deficient E.coli strain to avoid contamination of endogenous MutY. Despite high expression levels, most hMYH was insoluble (data not shown) and we were able to obtain only partially purified hMYH proteins after nickel-agarose purification (supplementary Figure 1 is available at Carcinogenesis Online). Using oligonucleotide substrates with the A:8oxoG at a defined position, hMYH DNA glycosylase activity can be monitored by running denaturating polyacrylamide gels, where the cleaved product (C) after NaOH treatment will migrate faster than the intact substrate (I; Figure 2A). DNA glycosylase activity assays revealed that the mutant enzymes hMYH H434D and hMYH S501F removed adenines from duplex oligonucleotides containing A:8oxoG base pairs at rates comparable with wild-type (WT) hMYH (Figure 2A). Contrary, for a substrate containing an A:G mispair, hMYH H434D activity was severely reduced (4% cleavage as compared with 36% for WT hMYH with 18 ng enzyme), whereas the S501F mutant showed the same A:G DNA glycosylase activity as intact hMYH (Figure 2A). The mutant form hMYH R260Q displayed reduced ability to excise adenines from an A:8oxoG duplex, cleaving only 15% of the substrate as compared with complete removal by WT hMYH with 18 ng enzyme (Figure 2A). By increasing the amount of hMYH R260Q up to 240 ng, 40% cleavage of the A:8oxoG duplex was obtained (Figure 2B). For A:G-containing substrates, R260Q was almost inactive (1% compared with 36% cleavage by WT hMYH with 18 ng enzyme) (Figure 2A). Despite its reduced DNA glycosylase activity, EMSAs revealed that R260Q has retained the ability to bind A:8xoG-containing duplexes and for the A:G substrate R260Q binds even stronger than the WT hMYH (Figure 2C). It appears that the hMYH R260Q substitution results in loss of the ability to discriminate between A:8oxoG and A:G when binding to DNA. The mutant hMYH S501F binds the two substrates with similar affinities as the WT enzyme, whereas no shift was observed with the H434D mutant neither for A:8oxoG nor for A:G substrates (Figure 2C). With higher protein concentration, H434D could bind weakly to the A:G substrate but not to A:8oxoG (data not shown). Under conditions for EMSA, no cleavage of the DNA substrates was observed as assayed by running a small sample of the reaction mixture on a denaturing/urea gel (data not shown). In summary, two of the hMYH mutations identified (R260Q and H434D) lead to proteins with defect DNA glycosylase activity.
###end p 35
###begin p 36
###xml 28 29 28 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 438 439 432 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 665 681 641 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 790 791 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 665 681 <span type="species:ncbi:562">Escherichia coli</span>
Analysis of hMYH variants. (A) Adenine DNA glycosylase activities of hMYH WT, R260Q, H434D and S501F variants were measured by incubating the respective proteins (18 ng) with a duplex oligodeoxyribonucleotide containing a single A:8oxoG or A:G basepair at 37degreesC for 30 min. Strand cleavage after NaOH treatment was analyzed by 20% polyacrylamide gel electrophoresis and phosphorimaging (I = intact strand and C = cleavage product). (B) Different amounts (0.6-240 ng) of hMYH WT (square), R260Q (black triangle), H434D (X) and S501F (*) were assayed for A:8oxoG DNA glycosylase activities and percentage strand cleavage quantified with ImageQuant. Extract from Escherichia coli cells expressing empty vector and purified similarly as hMYH was used to measure the background level (⧫). (C) DNA binding properties of hMYH WT, R260Q, H434D and S501F (24 ng) to substrates containing A:8oxoG (left panel) or A:G (right panel). After incubation on ice, DNA-protein complexes (B = bound substrate) were separated from free DNA (F) by 10% native polyacrylamide gel electrophoresis. Control lanes were without addition of protein.
###end p 36
###begin title 37
Analysis of hOGG1
###end title 37
###begin p 38
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 340 349 340 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 415 429 415 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 579 588 579 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 684 693 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 380 386 <span type="species:ncbi:562">E.coli</span>
Sequencing of hOGG1 revealed five novel mutations: one in the control group (G308E) and four in PSC patients (S31P, V58 synonymous, G342 synonymous and T398S; Table I). As two of the mutations found in the PSC group are silent mutations and one is conservative (T398S), we proceeded with functional studies of the hOGG1 S31P mutation only (Figure 1B). hOGG1 S31P was expressed in E.coli, purified ( is available at Carcinogenesis Online) and subjected to 8oxoG DNA glycosylase analysis. hOGG1 S31P showed the same capacity as WT hOGG1 to remove 8oxoG from an 8oxoG:C DNA duplex (Figure 3A). EMSA reveals that WT and S31P bind with the same affinity to an 8oxoG:C DNA oligonucleotide (Figure 3B). The alteration S31P does not seem to affect the activity nor DNA binding capacity of hOGG1.
###end p 38
###begin p 39
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 415 416 409 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Analysis of hOGG1 variants. (A) 8oxoG DNA glycosylase activity of S31P compared with WT hOGG1. A total of 3 and 10 ng enzymes were incubated with an 8oxoG:C oligonucleotide at 37degreesC for 30 min before cleavage of the phosphodiester backbone by NaOH. The reaction products were separated by 20% polyacrylamide gel electrophoresis and visualized by phosphorimaging. (I = intact strand and C = cleavage product). (B) DNA binding properties of hOGG1 WT and S31P. WT and S31P hOGG1 (10, 30 and 100 ng) were incubated with 8oxoG:C DNA on ice and DNA-protein complexes (B = bound substrate) were separated from free DNA (F) by 10% native polyacrylamide gel electrophoresis. Control lanes were without addition of protein.
###end p 39
###begin title 40
Analysis of NEIL1
###end title 40
###begin p 41
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 256 262 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 772 786 772 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 863 877 863 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Carcinogenesis</italic>
###xml 1038 1040 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 1041 1043 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1286 1295 1279 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 1412 1414 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 1769 1778 1762 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 2028 2037 2021 2030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 256 262 <span type="species:ncbi:562">E.coli</span>
###xml 607 613 <span type="species:ncbi:562">E.coli</span>
In NEIL1, three novel mutations were found; one in the PSC group (E181K), one in the PSC-CCA group (H275 synonymous) and one in the healthy control group (R339W). E181K and the SNP G83D were subjected for functional studies. Based on a comparison with the E.coli endonuclease VIII structure in complex with DNA (34), glycine 83 is found in a loop that forms part of the groove of NEIL1 in which the DNA is expected to bind, whereas glutamate 181 is a conserved residue within the helix-2-turn-helix motif that interacts with the lesion-containing strand (Figure 1C). The NEIL1 E181K protein was produced in E.coli, but the protein formed inclusion bodies and we were not able to obtain a pure preparation. NEIL1 G83D was purified to apparent homogeneity ( is available at Carcinogenesis Online), tested for co-purifying contaminating activities ( is available at Carcinogenesis Online) and assayed toward several oxidative DNA lesions known to be removed by NEIL1. Because NEIL1 has been shown to process beta,delta-elimination activity (30,35), its activity assay does not need NaOH treatment to detect strand breaks as for hMYH and hOGG1. In contrast to the WT enzyme, NEIL1 G83D showed no activity on 8oxoG:C duplex DNA and had strongly impaired cleavage activity on DHT duplex DNA (Figure 4A). The residual mutant activity on DHT:A was <10% of WT activity. WT NEIL1 is shown previously not to possess 8oxoG (36) or DHT DNA glycosylase activity on single-stranded DNA (ssDNA; our unpublished observation). As expected, the G83D mutant protein showed no activity on ssDNA containing a single 8oxoG or DHT (data not shown). Another oxidative pyrimidine lesion cleaved by NEIL1 is Tg. WT Neil1 has higher activity for Tg in double-stranded DNA than in single stranded (Figure 4A). The mutant G83D had weak activity for Tg in double-stranded DNA and almost no cleavage was observed for the single-stranded Tg substrate. Moreover, removal of formamidopyrimidine by G83D NEIL1 was strongly impaired as compared with the WT enzyme (Figure 4B). These data demonstrate an important role of Gly83 in substrate recognition.
###end p 41
###begin p 42
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 453 454 433 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 612 613 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 642 643 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 946 947 900 901 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Analysis of NEIL1 variants. (A) DNA glycosylase activity of G83D compared with WT NEIL1. Enzymes (2, 5, 10 and 20 ng) were incubated with different oligonucleotide substrates as indicated at 37degreesC for 30 min. The reaction products were separated by 20% polyacrylamide gel electrophoresis and visualized by phosphorimaging. (I = intact strand, C = cleavage product, beta = beta elimination, delta = delta elimination cleavage, ss = single strand). (B) FaPy DNA glycosylase activity of NEIL1 WT (⧫) and G83D (blacksquare, square, filled). Enzymes (3, 10, 30 and 100 ng) were assayed for removal of faPy from [3H]-methyl-faPy-poly(dG.dC). (C) DNA binding properties of NEIL1 WT and G83D. NEIL1 WT and G83D (20, 50 and 100 ng) were incubated with 5ohC:G DNA on ice and DNA-protein complexes (B = bound substrate) were separated from free DNA (F) by 10% native polyacrylamide gel electrophoresis. Control lanes were without addition of protein. (D) Nuclear localization of NEIL1 G83D and E181K. Asynchronous growing HeLa S3 cells were transiently transfected with constructs expressing NEIL1-EGFP, NEIL1G83D-EGFP or NEIL1E181K-EGFP. Cells were imaged directly by fluorescence microscopy for EGFP detection. DNA was stained with Hoechst 33342.
###end p 42
###begin p 43
###xml 159 168 159 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 359 368 359 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 980 989 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
Next, we tested NEIL1 G83D activity toward other oxidative pyrimidine lesions such as 5ohC and 5ohU. In contrast to the data above, NEIL1 G83D cleaved 5ohC:G (Figure 4A) and 5ohU:G (data not shown) duplex DNA at the same efficiency as the WT enzyme (Figure 4A). Also for 5ohC and 5ohU on ssDNA, G83D showed almost the same cleavage activity as the WT enzyme (Figure 4A). However, NEIL1 G83D showed significantly reduced delta-elimination activity (50%) as compared with the WT enzyme for both single-stranded substrates. With high concentration of G83D and 5ohC and 5ohU ssDNA substrates, there appears to be some 5'-phosphtase or ssDNA nuclease contamination in the reactions. As this is not observed for the Tg single-stranded substrate, the possible contaminating activity might be sequence dependent. To further characterize NEIL1 G83D, EMSAs were performed. The results reveal that G83D binds to 5ohC:G DNA substrate with slightly reduced affinity as compared with WT NEIL1 (Figure 4C). In the lane with the highest concentration of WT NEIL1 (100 ng), there is a 25% reduction in total signal intensity that might be ascribed to copurifying contaminating 5'-phosphatase/exonuclease activity.
###end p 43
###begin p 44
###xml 273 282 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
To further investigate the role of the G83D mutation on the beta,delta-reaction, we examined cleavage of a duplex oligonucleotide containing a single abasic site. Surprisingly, we find that the mutant enzyme incise the abasic site more efficiently (two times) than the WT (Figure 4A). However, only 50% of the cleaved abasic site has been fully processed to the delta-elimination end product by NEIL1 G83D, whereas 50% of the cleaved product remains as the beta-elimination intermediate. With WT NEIL1 almost 100% of the cleavage product has been fully processed to the delta-elimination product. It thus appears that the NEIL1 G83D mutation modulates the catalytic capacity of NEIL1 as well as substrate specificity.
###end p 44
###begin p 45
###xml 218 227 218 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 497 506 497 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 582 588 <span type="species:ncbi:562">E.coli</span>
Intracellular localization studies have revealed that NEIL1 is located to the nucleus of human cells with an accumulation in the nucleoli and a putative nuclear localization signal is found in the C-terminus of NEIL1 (Figure 1C) (30). Constructs of NEIL1 G83D and E181K fused to enhanced green fluorescent protein were generated and used for transfection of HeLa S3 cells. Fluorescence microscopy showed that the distribution of the NEIL1 mutants was confined to the nucleus as seen for WT NEIL1 (Figure 4D). Although we were not able to purify recombinant NEIL1 E181K expressed in E.coli, the corresponding fusion protein localized as WT NEIL1 in HeLa cells indicating that the mutant is folded and distributed correctly in mammalian cells.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 440 448 <span type="species:ncbi:9606">patients</span>
PSC is a chronic inflammatory disorder of the bile ducts in which the patients have a high risk for developing CCA. In order to better understand individual susceptibility to CCA, we evaluated the role of SNPs and germ line mutations in genes involved in the repair of oxidative DNA damage. Eighteen genetic variants were identified, six were validated SNPs, whereas 12 were new mutations. Three rare variants identified in PSC and PSC-CCA patients were found to critically affect protein function (hMYH R260Q, hMYH H434D and NEIL1 G83D).
###end p 47
###begin p 48
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 803 808 <span type="species:ncbi:9606">human</span>
Importantly, there is increasing awareness of the contribution from rare variants to the genetic susceptibility of complex traits (37). The detection of such variants is inert to the association study design and requires resequencing of entire study populations with subsequent assessment of functional consequences of identified variants (reviewed in ref. 38). Noteworthy, the three variants with severe consequence for the BER pathway were found among patients with PSC with or without CCA. The lack of overall association between any of the investigated variants and PSC or CCA susceptibility may clearly result from lack of statistical power. For instance, it is well established that the oxidative DNA lesion 8-oxoguanine is mutagenic and that hOGG1 represents the major 8oxoG removing activity in human cells. hOGG1 S326C is the most studied SNP in hOGG1 and is weakly associated with some cancers (14) and has reduced 8oxoG DNA glycosylase activity (39). Power calculations based on previous studies of this SNP [odds ratio of GG versus CC genotypes >2.0; (14)] emphasized limitations of the genetic association study design (0.11 for PSC-CCA versus PSC without CCA, 0.14 for PSC-CCA versus healthy controls; ) to conclusively clarify whether this mutation may play a role in cholangiocarcinogenesis in PSC. Although comparable frequencies of S326C were observed in all three study populations, the possibility thus needs to be kept open that weak effects on CCA susceptibility from this variant may exist.
###end p 48
###begin p 49
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 134 138 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 184 186 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 266 270 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 357 359 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 513 515 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 516 518 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 695 699 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 963 965 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 966 968 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">43</xref>
###xml 1002 1008 990 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1010 1012 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 1154 1160 1142 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1494 1503 1482 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1686 1690 1674 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 584 591 <span type="species:ncbi:9606">patient</span>
###xml 670 677 <span type="species:ncbi:9606">patient</span>
Two common hMYH mutations associated with colorectal adenoma polyposis are Y165C and G382D, which account for approximately73% of all hMYH mutations reported to date (reviewed in ref. 40). Neither of these two mutations was found in our study. To date >80 different hMYH mutations have been described in MutY associated-polyposis patients (reviewed in ref. 41). Approximately 15% of these mutations have been subjected to functional studies and several of the mutants show reduced or no DNA glycosylase activity (41,42). The catalytically impaired hMYH variant R260Q was found in one patient carrying this mutation on one allele. The importance of the mutation for this patient is uncertain, as hMYH mutations associated with colon cancer are autosomal recessive. However, R260Q still binds DNA and may prevent access for WT hMYH to A:8oxoG pairs. The same mutation was also identified in a large multisite, population-based colorectal cancer case-control study (42,43) and was further analyzed by Ali et al. (42). Similarly as in this work, reduced A:8oxoG activity was found for R260Q. Our data show that R260Q has normal A:8oxoG binding, however, Ali et al. reported that the mutant has reduced A:8oxoG DNA-binding property. We do not know the reason for the discrepancy but different assay conditions could contribute. The catalytic impairment of hMYH R260Q was unexpected from a structural point of view as R260 is located on the surface of MutY pointing away from the active site pocket (Figure 1A). From the structure, this residue is predicted to have no role in catalysis or in DNA binding as the distance from R260 to the adenine-binding pocket is >16 A. Future screening for hMYH associated mutations in cancer should also include R260Q.
###end p 49
###begin p 50
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
The C-terminal domain of MutY is required for 8oxoG recognition and deletion of this domain results in a protein with reduced binding affinity and DNA glycosylase activity for A:8oxoG but not for A:G (44,45). The H434 residue is a conserved residue within the C-terminal domain and is part of a loop that intercalates the DNA and makes contacts with the sugar-phosphate backbone 5' to the oxidized guanine. The presence of aspartate in this position will result in a negative charge and repulsion of the DNA, as demonstrated by the lack of shift in the EMSAs for hMYH H434D. Interestingly, the H434D mutant has the same DNA glycosylase activity for A:8oxoG as WT hMYH; however, the ability to excise adenine from A:G mispairs is significantly reduced, supporting a previous observation that the C-terminal domain is not only involved in 8oxoG recognition but also affects binding and catalytic activities toward A:G mismatches (46).
###end p 50
###begin p 51
###xml 152 154 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 1124 1130 1103 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1132 1134 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
The NEIL1 G83D mutant has been shown previously to lack DNA glycosylase activity toward Tg and faPy lesion but has beta-elimination activity on AP DNA (47). Presumably, the gain of the acidic aspartate alters the surface of the active site of NEIL1 that is dominated by basic amino acid side chains in the WT enzyme. Here, we show that the DNA glycosylase activity for G83D is lost only for 8oxoG, DHT and Tg, substrates that all need to be in a context of double-stranded DNA for NEIL1 to cleave. For lesions known to be substrates for NEIL1 also when present in ssDNA (5ohC, 5ohU), G83D is as active as WT NEIL1. In addition to compromised DNA glycosylase activity for G83D for some substrates, the delta-elimination reaction is also affected. After incubation with G83D, about half of the substrate was cleaved by beta,delta-elimination and the other half by beta-elimination only. This was most evident for the single-stranded substrates (5ohC, 5ohU) and for the AP DNA. It thus appears that introduction of an aspartic residue at this position directly or indirectly affects residues involved in delta-elimination. Roy et al. (47) reported that G83D yielded primarily beta-elimination only. We do not know the reason for this discrepancy but might be due to different assay conditions, variation during expression and purification or the sequence context of the DNA substrate.
###end p 51
###begin p 52
###xml 76 82 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 76 82 <span type="species:ncbi:562">E.coli</span>
Residue G83 is part of a loop connecting beta-strands 4 and 5, which in the E.coli EndoVIII structure includes the essential DNA-intercalating residue Leu70 (corresponding to Met81 in NEIL1). Modeling of aspartate in position 83 of NEIL1 suggests that this mutation alter the conformation of this loop, as the negatively charged aspartate side chain is pointing into a hydrophobic pocket in NEIL1. Significant rearrangement of this loop is expected in order to remove unfavorable steric and electrostatic conflicts following a mutation of Gly83 into Asp. Interestingly, according to our model, this loop is close to the non-lesion-containing strand, supporting the observed effect on double-stranded substrates only.
###end p 52
###begin p 53
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
The NEIL1 G83D SNP was found in two PSC patients with CCA and both were heterozygotic for this polymorphism. As the other allele is healthy, the cells are probably to function with approximately half the level of normal NEIL1 activity. In tissue with severe oxidative stress, such as the bile ducts of PSC patients, a reduction in the DNA repair functions could lead to high levels of oxidative DNA damage and consequently, an increase in the incidence of gene mutations might be the result. Further, defect in one allele could be fatal if the other allele acquires mutations during initial stages of carcinogenesis. It has been estimated that a 20-35% reduction in repair capacity of cells is associated with a 4- to 6-fold higher risk of developing cancer (48).
###end p 53
###begin p 54
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1</italic>
###xml 345 352 <span type="species:ncbi:9606">patient</span>
An expression study has shown previously that the NEIL1 messenger RNA level was reduced in about half of primary gastric cancer specimens examined indicating a role of NEIL1 in preventing cancer development (12). Variations in expression levels of NEIL1 and also of the other DNA repair genes analyzed may also be of significance for CCA in PSC patient. However, the infiltrating nature of CCA tumors makes it difficult to obtain pure tumor material and such a study awaits further work.
###end p 54
###begin p 55
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hOGG1</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEIL1.</italic>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
In conclusion, by sequencing a panel of genes encoding proteins of the BER pathway in patients with PSC, PSC and CCA and healthy controls, we detected nine novel non-synonymous mutations in hMYH, hOGG1 and NEIL1. Although no statistical significant differences in allele frequencies between any of the investigated groups were found, severe impairment of protein function was evident in extensive functional analysis of three mutations found in patients with PSC and PSC with CCA. In statistical terms, a causal relationship between either of these mutations and carcinogenesis and PSC is difficult to conclude. Nevertheless, our present findings add to increasing knowledge of the importance of rare, coding variants in complex diseases (37,49) and hint to the usefulness of massive sequencing in the search for genetic variants that influence the individual susceptibility to cancer development.
###end p 55
###begin title 56
Supplementary material
###end title 56
###begin p 57
 and  and  and  can be found at
###end p 57
###begin title 58
[Supplementary Data]
###end title 58
###begin title 59
Funding
###end title 59
###begin p 60
###xml 0 24 0 24 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Norwegian Cancer Society</funding-source>
###xml 26 52 26 52 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Norwegian Research Council</funding-source>
###xml 54 91 54 91 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rikshospitalet University Hospital HF</funding-source>
Norwegian Cancer Society; Norwegian Research Council; Rikshospitalet University Hospital HF.
###end p 60
###begin title 61
Abbreviations
###end title 61
###begin p 62
base excision repair
###end p 62
###begin p 63
cholangiocarcinoma
###end p 63
###begin p 64
dihydrothymine
###end p 64
###begin p 65
enhanced green fluorescent protein
###end p 65
###begin p 66
electrophoretic mobility shift assay
###end p 66
###begin p 67
5-hydroxy cytosine
###end p 67
###begin p 68
5-hydroxy uracil
###end p 68
###begin p 69
7,8-dihydro-8-oxoguanine
###end p 69
###begin p 70
primary sclerosing cholangitis
###end p 70
###begin p 71
single-nucleotide polymorphism
###end p 71
###begin p 72
single-stranded DNA
###end p 72
###begin p 73
thymine glycol
###end p 73
###begin p 74
wild-type
###end p 74
###begin p 75
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMYH</italic>
pGEV1-hMYH was a gift from A-Lien Lu (Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD, USA). Benedicte A.Lie and Norwegian Bone Marrow Donor Registry (Institute of Immunology, Rikshospitalet, Oslo, Norway) are acknowledged for providing the healthy control population.
###end p 75
###begin p 76
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest Statement:</italic>
Conflict of Interest Statement: None declared.
###end p 76
###begin article-title 77
Oxidant are major contributor to cancer and aging
###end article-title 77
###begin article-title 78
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer
###end article-title 78
###begin article-title 79
Repair of DNA containing the oxidatively-damaged base, 8-oxoguanine
###end article-title 79
###begin article-title 80
The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine)
###end article-title 80
###begin article-title 81
###xml 39 44 <span type="species:ncbi:9606">human</span>
DNA base modifications in chromatin of human cancerous tissues
###end article-title 81
###begin article-title 82
Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors
###end article-title 82
###begin article-title 83
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH
###end article-title 83
###begin article-title 84
The interacting pathways for prevention and repair of oxidative DNA damage
###end article-title 84
###begin article-title 85
Base-excision repair of oxidative DNA damage
###end article-title 85
###begin article-title 86
Oxidative DNA damage repair in mammalian cells: a new perspective
###end article-title 86
###begin article-title 87
###xml 30 35 <span type="species:ncbi:9606">human</span>
Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer
###end article-title 87
###begin article-title 88
Associations between hOGG1 sequence variants and prostate cancer susceptibility
###end article-title 88
###begin article-title 89
Polymorphisms in DNA repair genes and associations with cancer risk
###end article-title 89
###begin article-title 90
Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C->T:A mutations
###end article-title 90
###begin article-title 91
Repair of the oxidative DNA damage 8-oxoguanine as a biomarker for lung cancer risk
###end article-title 91
###begin article-title 92
Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer
###end article-title 92
###begin article-title 93
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology
###end article-title 93
###begin article-title 94
Risk factors in primary sclerosing cholangitis
###end article-title 94
###begin article-title 95
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
###end article-title 95
###begin article-title 96
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis
###end article-title 96
###begin article-title 97
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study
###end article-title 97
###begin article-title 98
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
###end article-title 98
###begin article-title 99
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
###end article-title 99
###begin article-title 100
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage
###end article-title 100
###begin article-title 101
Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel
###end article-title 101
###begin article-title 102
###xml 31 36 <span type="species:ncbi:9606">human</span>
Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis
###end article-title 102
###begin article-title 103
###xml 39 44 <span type="species:ncbi:9606">human</span>
Opposite base-dependent reactions of a human base excision repair enzyme on DNA containing 7,8-dihydro-8-oxoguanine and abasic sites
###end article-title 103
###begin article-title 104
###xml 63 87 63 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 159 175 159 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 63 87 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 159 175 <span type="species:ncbi:562">Escherichia coli</span>
Base excision of oxidative purine and pyrimidine DNA damage in Saccharomyces cerevisiae by a DNA glycosylase with sequence similarity to endonuclease III from Escherichia coli
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA
###end article-title 105
###begin article-title 106
Structural basis for removal of adenine mispaired with 8-oxoguanine by MutY adenine DNA glycosylase
###end article-title 106
###begin article-title 107
Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA
###end article-title 107
###begin article-title 108
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human endonuclease VIII-like 1 (NEIL1) reveals a zincless finger motif required for glycosylase activity
###end article-title 108
###begin article-title 109
###xml 26 42 26 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 26 42 <span type="species:ncbi:562">Escherichia coli</span>
Structural analysis of an Escherichia coli endonuclease VIII covalent reaction intermediate
###end article-title 109
###begin article-title 110
###xml 41 46 <span type="species:ncbi:9606">human</span>
Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA
###end article-title 110
###begin article-title 111
###xml 53 58 <span type="species:ncbi:9606">human</span>
Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2
###end article-title 111
###begin article-title 112
###xml 74 82 <span type="species:ncbi:9606">patients</span>
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
###end article-title 112
###begin article-title 113
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
###end article-title 113
###begin article-title 114
###xml 87 92 <span type="species:ncbi:9606">human</span>
Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects
###end article-title 114
###begin article-title 115
MutYH (MYH) and colorectal cancer
###end article-title 115
###begin article-title 116
MUTYH-associated polyposis-from defect in base excision repair to clinical genetic testing
###end article-title 116
###begin article-title 117
Characterization of mutant MUTYH proteins associated with familial colorectal cancer
###end article-title 117
###begin article-title 118
###xml 14 19 <span type="species:ncbi:9606">human</span>
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study
###end article-title 118
###begin article-title 119
The C-terminal domain of the adenine-DNA glycosylase MutY confers specificity for 8-oxoguanine.adenine mispairs and may have evolved from MutT, an 8-oxo-dGTPase
###end article-title 119
###begin article-title 120
The C-terminal domain of MutY glycosylase determines the 7,8-dihydro-8-oxo-guanine specificity and is crucial for mutation avoidance
###end article-title 120
###begin article-title 121
###xml 25 41 25 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 25 41 <span type="species:ncbi:562">Escherichia coli</span>
The C-terminal domain of Escherichia coli MutY is involved in DNA binding and glycosylase activities
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human polymorphic variants of the NEIL1 DNA glycosylase
###end article-title 122
###begin article-title 123
Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?
###end article-title 123
###begin article-title 124
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia
###end article-title 124

